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Summary.-Cells from a C57BL/cbi chemically induced fibrosarcoma (FS6) require
exogenous platelet-derived growth factor (PDGF) for in vitro proliferation (as do
normal "untransformed" fibroblasts) whereas cells obtained from the FS6M1
tumour, a spontaneous metastasizing subline, show autonomy from PDGF in vitro.
Furthermore, the FS6 cells exhibit very low colony formation in an anchorage-
independent growth assay. In vivo, this tumour is immunogenic, rarely metastasizes
and is heavily infiltrated by host macrophages. Studies of in vitro cell proliferation
and anchorage-independent growth show that syngeneic host macrophages from the
peritoneal cavity or from the growing tumour release a diffusible factor(s) which has
(1) growth-stimulating activity on FS6 cells in monolayer cultures in PDGF-poor
medium and (2) potent colony-stimulating activity on FS6 cells cultured in methyl-
cellulose-containing medium. These macrophage supernatants stimulate prolifera-
tion of quiescent normal fibroblasts in monolayer culture as well as FS6 sarcoma
cells, but do not stimulate anchorage-independent growth of normal cells.
Supernatants from BCG-elicited macrophages were shown to contain abundant
arginase, and were cytolytic to FS6 cells but not to normal cells. Heat inactivation
abrogated the arginase and cytotoxicity, revealing heat-stable mitogenicity for FS6
cells and normal fibroblasts.
Thestimulatoryeffectofmacrophages onFS6 sarcomacells canbe mimicked bythe
addition of the tumour promoter 12-tetradecanoyl-phorbol-13-acetate (TPA) and
supports the hypothesis that macrophages could play a significant role in multistage
carcinogenesis by providing a source of endogenous promoter.
IN 1922, Carrel showed that leucocytes
from the blood or peritoneal cavity of
chickens contain and release factor(s)
which stimulate the growth of fibroblasts
in tissue culture. Leibovich & Ross (1975,
1976) in studies of wound healing in
guinea-pigs, suggested that macrophage
infiltration may play a vital role in initia-
ting the proliferation of fibroblasts, and
they also showed that peritoneal-exudate
macrophages maintained in vitro release
a heat-stable non-dialysable fibroblast
mitogen. Vascularproliferation inresponse
to a macrophage product was described
by Polverini et al. (1977) and macrophages
derived directly from wounds were shown
by Greenburg & Hunt (1978) to release
potent mitogenicity for both endothelial
andsmooth-muscle cells. Apotentmitogen
for fibroblasts has been detected in cul-
tures of human monocytes (DeLustro
etal., 1980).
The growth-promoting activity of mac-
rophages has also been incriminated in
the natural history of tumours. Evans
(1977) studied a murine fibrosarcoma
(FS6) and concluded that host macro-
phages infiltrating the growing tumour
may in some unknown way promote its
growth. He subsequently reviewed the
topic (Evans, 1979) and argued that host
macrophages may play a vital role in the
development of tumours. Salmon & Ham-
burger (1978) suggested that macrophage-PROMIOTION OF FIBROSARCOAIA IY MIACROPHAGES
derived factors may play such a role in
promoting clonal proliferation of malig-
nant cells, and could act as endogenous
"promoters" analogous to the role of
phorbol esters in multistage carcinogenesis.
While examining the proliferative capa-
city of cells from rodent mesenchymal
tumours in plasma-derived serum (PDS)
and their responses to platelet-derived
growth factor (PDGF) we noted (Currie,
1981) that some tumours (including the
FS6 sarcoma described by Evans, 1977)
required an exogenous source of PDGF
to proliferate in vitro. Furthermore,
tumours found to be dependent on PDGF
were those which, when implanted into
the syngeneic host, attract large numbers
of host macrophages, are immunogenic
and rarely metastasize spontaneously
(Currie, 1981).
The experiments described below lend
weight to the hypothesis of Salmon &
Hamburger (1978) and indicate that host
macrophages infiltrating the FS6 sarcoma
may stimulate tumour growth by releasing
material mitogenic for FS6 sarcoma cells
and for normal fibroblasts. Furthermore,
such macrophage product(s) greatly en-
hance anchorage-independent growth of
FS6 sarcoma cells but not of normal fibro-
blasts. The in vivo expression ofthe malig-
nant phenotype by these cells may, there-
fore, be dependent upon "endogenous pro-
motion" by products of infiltrating host
macrophages.
MATERIALS AND METHODS
Fibrosarconias.-The FS6 fibrosarcoma, in-
duced by benzo(a)pyrene in C57BL/cbi mice,
was s.c. transplanted every 3 weeks using
trocar fragments. All studies of this tumour
were performed between in vivo Passages 5
and 9, and at Passage 9 were replenished
from Passage 4 stocks held in liquid N2. It is
slow growing and rarely gives rise to distant
metastases at these early passages. It is
immunogenic in syngeneic mice by conven-
tional transplantation-rejection criteria, and
the growing tumour mass in ivo is heavily
infiltrated by host macrophages. It was used
and described by Evans (1977). The FS6M1
is a variant subline of the FS6 which arose
during transplantation of FS6 in C57BL/6
mice in the laboratories of Dr A. Mantovani
(1978). When transplanted back into its
syngeneic host strain (C57BL/cbi) this tumour
is weakly immunogenic, induces a high inci-
dence of distant metastases and contains
fewer host macrophages than the parent FS6.
It was handled and transplanted in a manner
similar to the FS6, and was used within 10
passages from its receipt back into these
laboratories.
Tumour macrophages.-Fragments of FS6
tumour were washed, chopped and disaggre-
gated with 0-1% collagenase (Type 1, Sigma)
and 0.01% DNAse (Type 1, Sigma). The
resulting cell suspension was filtered through
gauze and washed in Hanks' balanced salt
solution. The cells were counted, suspended
at 106/ml in arginine-free RPM1 1640 con-
taining 10mM HEPES, penicillin, strepto-
mycin and neomycin, and 5 ml was added to
60mm plastic Petri dishes. These cultures
were incubated overnight at 37°C in 500 CO2
in humid air. The cultures were then washed
vigorously to remove dead and non-adherent
cells. Examination ofthe resulting cell mono-
layers for Fc receptors by the addition of
appropriately sensitized sheep erythrocytes
revealed that over 9500 of the cells possessed
Fe receptors, and after reincubation at 37°C
for 30 min were intensely phagocytic. These
cells were trypsin-resistant, and when cul-
tured in complete medium (see below)
showed no evidence of proliferation.
Peritoneal-exudate cells were obtained by
lavage from normal C57BL/cbi mice, or from
mice which had previously received i.p. in-
jections of 1 ml thioglycollate medium, 1 ml
10% proteose-peptone (4 days previously) or
300 Hug Glaxo BCG (14 days previously).
Plasma-derived serum (PDS) and whole-
bloodserum (WBS) were obtained from normal
healthy volunteers by methods previously
described (Currie, 1981).
Cell cultures.-Enzyme-disaggregated cell
suspensions from FS6 and FS6M1 (as above)
were cultured in 25cm2 plastic flasks in
RPM1 1640 containing 10% heat-inactivated
foetal bovine serum (FCS), antibiotics and
HEPES (complete medium). They were
passaged twice weekly using 0-10% trypsin,
and were used between Passages 2 and 10,
and were regularly replenished from Passage 2
stocks. The uncloned cultures from both
tumours were tumorigenic when tested in
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syngeneic mice at Passages 2 and 10.
Although it has not been assayed by radio-
immunoassay, the batch of FCS contained
high levels of PDGF by bioassay (unpub-
lished).
The following cells were also used as targets
in growth assays: BHK21C13 and PyY
respectively, untransformed and polyoma
virlus-transformed lines of baby hamster
kidney cells (from Flow Laboratories Ltd);
NLF1, a culture derived from an explant of
chopped lung tissue of a male C57BL/cbi
mouse is a characteristic normal fibroblast.
These cells were also cultured in RPM1 1640
containing antibiotics, 20mM HEPES and
10% FCS. They were all grown as stock cul-
tures in 25cm2 disposable plastic flasks, and
were passaged frequently to maintain ex-
ponential growth. They were routinely
screened for mycoplasma contamination by
Bisbenzimide H33258 fluorescence (Chen,
1977) and were negative throughout these
experiments. All cell lines were studied within
10 in vitro passages and were regularly re-
plenished from low-passage stocks.
Cell-proliferation assay.-The assay was
performed exactly as described earlier (Currie,
1981). In brief, 2 x 103 cells were grown in
100l volumes in Microtest II plates and cell
numbers estimated at intervals on formalin-
fixed cells, using a methylene-blue binding
assay read in a Multiskan 8-channel photo-
meter. Growth curves (as absorbance at
650 nm, A650) were plotted on log paper and
cell-population doubling time measured. Sex-
tuplicate wells were examined at each
observation. The Multiskan was blanked on
control wells which had contained cell-free
medium. Data from this assay were also used
to derive figures for percentage growth at
48 h; i.e. data from the test samples were
compared to the nil control and any percent-
age increase (or decrease) in optical densities
calculated as percentage change.
% Growth=
A650 test at 48 h -A650 at Time ° 100
A650 at Time 0 x
Arginase assay.-Levels of arginase in the
culture medium were assayed by a radio-
isotope method using 14C-guanidino-arginine.
Details of this method will be published
separately (Ould & Currie, in preparation).
Anchorage-independent growth.-Cells were
suspended in complete medium containing
1.2% methylcellulose (Methocel A4M, Dow
Chemical Co.) at 2-5 x 102 or 2-5 x 103/ml and
4 ml poured into 60mm plastic Petri dishes
containing a 2ml underlay comprising 0.6%
LGT agarose (Marine Colloids Inc.) in com-
plete medium.
For some experiments - 2 x 106 macro-
phages (proteose-peptone elicited or obtained
from the FS6 tumour) were plated in the
Petri dishes in complete medium and allowed
to adhere at 37°C for 2 h. The dishes were then
vigorously washed free of non-adherent cells
and the remaining macrophage monolayer
overlayed with 0 6% agarose which was
allowed to gel at room temperature before
target cells in 120% methylcellulose were
added. Control-culture underlays of 106
BHK21CI3 cells, FS6 or FS6M1 cells were
irradiated with X-rays under aerobic con-
ditions to a dose of 35 Gy before the addition
of target cells in methylcellulose. The cul-
tures were incubated for 14 days and the
colonies counted after staining in situ with
iodonitrotetrazolium violet. The results are
expressed as plating efficiency (i.e. the num-
ber of colonies counted as a percentage of the
number of target cells added PE).
Before staining the dishes, sample single
colonies were aspirated with a fine pipette
under stereomicroscopy, transferred to cul-
ture flasks containing 5 ml complete medium
and allowed to grow as monolayers. These
clones were subsequently retested for anchor-
age-independent growth as described above.
RESULTS
Growth of FS6, FS6M1, NLF1 and
BHK21C13 in PDS or WBS in monolayer
cultures
When cultured in RPM1 1640 contain-
ing 15% heat-inactivated WBS all 4 cell
lines grew equally well. However, in 15%
PDS the BHK21C13 cells, NLF1 and FS6
failed to proliferate and remained quies-
cent; but the FS6M1 grew as well in PDS
as in WBS. Growth curves of F86 and
FS6M1 are illustrated in Figs 1 & 2. When
an extract of human platelets (containing
5 u PDGF, Currie, 1981) was added to
FS6, NLF1 or to BHK21C13 in PDS they
grew rapidly: i.e. cells were dependent
upon exogenous growth factor, as were the
normal lung fibroblasts and normal ham-
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FIG. 1. Growth curves of FS6 and FS6MN1I
cells in medium containing plasma-derive(d
TABLE I.-Effect of macrophage super-
natants on doubling time of FS6 cells in
PDS in monolayer culture
Cell-
(loubling
time
Alacropliage supernatant (h)
Nil (control) > 100
Platelet extract (5 u) 14-2
Normal peritoneal 18 4
Proteose-peptone elicited 14 9
Proteose-peptone elicited and
exposeed to LPS (10 ,tg/ml) - 17-2*
FS6 tumour macrophages 15-0
BCG elicited - 21*
BCG elicited (heated) + 13-6
* Negative v-alue represenits lysis of cells.
serum (PDS). The results are shown as centrifuged and filtered through an 0-22-
absorbance at 650 nm, and are the means ,M filter (Millipore). Fifty-iLl volumes of
of sextuplicate observations. Bars indicate
total data spread. these supernatants, plus control media
from flasks incubated without cells, were
added to wells containing 50kl volumes
A6501 of RPM1 1640 medium containing FS6
cells and 30%o PDS, i.e. a final concentra-
tion of 15% PDS. All these experiments
1.0- were conducted insextuplicate, andgrowth
--- curves were constructed as before. The
--- results are shown in Table I and Fig. 2.
As the data show, the supernatant from
/- >' - - - - -normal resident peritoneal macrophages
induced proliferation of FS6 cells. Super-
natants from FS6 tumour-derived macro-
0.1 - phages also contained powerful growth-
promoting activity, providing cultures of
FS6 cells which proliferated as rapidly
020 40 60 80 as those exposed toplatelet-derivedgrowth
Hours factor. Peritoneal macrophages obtained
FIG. 2.Growth H curves ofFS6 cells in PDS to from mice injected with thioglycollate which was added control medium (0* *) provided supernatants with no detectable
platelet extract (0 0) and supernatant growth-promoting activity, whereas those from FS6 tumourmacrophages (O--- 0). elicited with proteose-peptone provided
very actively growth-promoting super- stercells.GrowthofFS6Ml wasunaffected natants. Macrophages elicited with BCG
by the addition of platelet extract. provided cytotoxic supernatants killing
FS6 and FS6MI cells. The normal cells Effect of macrophage supernatant on the were unaffected in that there was no
growth ofFS6 cells in monolayer cultures evidence of either growth promotion or
About 5 x 106 macrophages obtained cytotoxicity. Proteose-peptone-elicited
as described above were cultured in 4 ml macrophages exposed to 10jg/ml lipo-
serum-free RPM1 1640 medium for 48 h polysaccharide (Difco, E. coli 0555:B5)
and then the supernatants were collected, also provided cytotoxic supernatants.
I I
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Effect of macrophage supernatant on
BHK21C13 cells in monolayer culture
As can be seen from Table II, super-
natant media from normal peritoneal
macrophages (those elicited by proteose-
peptone or obtained within a growing
FS6 tumour) provided potent mitogenicity
for the BHK21C13 hamster fibroblasts.
However, supernatants from macrophages
elicited by BCG, or proteose-peptone mac-
rophages exposed to LPS endotoxin, had
no mitogenic effect on BHK21C13 cells.
They had no detectable cytotoxicity on
these cells, unlike their effects on FS6 cells.
TABLE II. Effect of macrophage super-
natants on doubling time of BHK21C13
cells in PDS in monolayer culture
AMacroplhage supernatant
Nil (control)
Platelet extracts (5 u)
Normal peritoneal
Proteose-peptone
Thioglycollate
BCG elicited
Proteose-peptone + LbS
(10 4g/ml)
FS6 tumour macropliages
Cell-
(loubling
time
(h1)
> 100
9-4
14-5
13 0
> 100
> 100
> 100
9 6
Arginase activity in macrophage super-
natants
The various macrophage supernatants
tested for growth-promoting activity were
also assayed for arginase content. Low
levels of arginase were present in all the
media containing growth-promoting acti-
vity. However, cytotoxic supernatants
(from BCG-elicited macrophages) con-
tained high levels of arginase (see Table
III).
Heat stability of macrophage-derived growth
factors
Supernatant media from FS6 tumour
macrophages were heated in a water bath
to 100°C for 10 min. They were then
centrifuged, filtered and tested for growth-
promoting activity on FS6, FS6ML and
the "normal" cells, NLF1 and BHK21C13.
Despite this vigorous treatment the
growth-promoting activity of these super-
natants was not decreased; indeed there
was evidence ofan increase. Since arginase
is heat labile, the cytotoxic supernatants
from BCG-elicited or LPS-treated macro-
phages were similarly heated and tested.
The cytotoxicity activity of these super-
natants was abolished by heating, and
growth-promotion became detectable. In
other words, the growth-promoting acti-
vityofthesesupernatants hadbeenmasked
by their cytotoxic arginase content. Heat-
ing led to a dramatic reduction in their
arginase content (Table III).
Anchorage-independent growth
BHK2lCl3 cellsproducedlessthan001
PE when cultured in methylcellulose-
containing medium. F86 sarcoma cells
produced colonies, but their PE was very
low (see Table IV). FS6M1 cells showed a
high PE (see Table V). When cultured
over a macrophage monolayer the PE
ofFS6 cells was greatly enhanced, whereas
FS6M1 were unaffected. Peritoneal-
exudate macrophages elicited by proteose-
peptone, and macrophages obtained
directly from the FS6 sarcoma, both
exhibited this potent stimulation on FS6
cells. Macrophage underlays, from either
source, showed no promoting effect on
TABLE III.-Arginase content of macrophage supernatants and their effects on growth of
FS6, FS6M1, YNLF1 and BHK2IC13 cells. Negative values represent cell lysis
Arginase
content Target cells (%o growth)
( iu urea/
MIacrophage supernatant min/ml) FS6 FS6M1 NLhF1 BHK21C13
Proteose-peptone induced 8-54 + 210 0 + 168 + 218
BCG induced 27 40 -63 -882 0 0
BCG induced (heated) 2-91 + 215 0 + 170 + 246
FS6 tumour macrophages 6-3 -190 0 + 140 + 204
FS6 tumour macrophages
(heated) +0 N.D. N.D.
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TABLE IV.-Effect ofmacrophage underlays
on colony formation of FS6 cells in
methylcellulose
Underlay
Nil
Proteose-peptone peritoneal
macrophages
FS6 tumour-derived
macrophages
FS6 sarcoma (35 Gy)
BHK21C13 (35 Gy)
* N.T. =not tested.
Subculture
PE PE
0 03 0-02
28 0-02
14-1 003
0-02 N.T.*
0-02 N.T.*
BHK21C13 which continued to show a
very low PE. The enhanced anchorage-
independent growth ofFS6 was reversible,
since clones derived from colonies from
these dishes reverted to a low PE when
retested without a macrophage underlay
(Table IV). Underlays of BHK21C13,
"C' ,% " C' _ j fr . I 1-- 'Io
TABLE VI.-Effect of macrophage super-
natant and TPA on anchorage-independ-
ent growthofFS6,FS6M1 andBHK2lCl3
cells in methylcellulose
Material added
Nil
FS6 tumour-derived
macrophage
supernatant 1: 5
TPA (ng/ml) 100
10
1
0-1
100 ng/ml, which
FS6 and FS6M1.
DIS
PE
, ~~~~A
FS6 FS6M1 BHK21C13
003 7-1 <0.01
7-8
0 09
1-4
11-2
< 0-01
7-0
0 4
6-7
7-4
1-0
< 0-01
< 0-01
< 0-01
< 0-01
< 0-01
was inhibitory to both
SCUSSION
F 6 or JFf6MV1I had no ef
formation by FS6 cells.
TABLE V.-Effect af macroj
on colonyformation (PE)
BHK21C13 cells in methy
Underlay
Nil
Proteose-peptone peritoneal
macrophages
FS6 tumour-derived
macrophages
F
Effect of TPA on anchor
growth ofFS6 cells
The potent tumour pro]
decanoyl-phorbol- 13-acetat
dissolved in acetone ar
medium. Equivalent con
acetone were used in the cc
of concentrations of TPA
the medium ofFS6, FS6M1
cells in methylcellulose ani
colony formation examinE
seen from Table VI, the a
no effect on the norrn
(BHK2lCl3). Significant e
colony formation by FS6
at 10 and lng/ml TPA. Co
by FS6M1 cells was unaffE
ffect on colony The use ofplasma-derived serum (PDS)
for the investigation of tumours of
mesenchymal origin has provided a useful
phage underlays approach to the examination of the role
ofFS6M1 and of "growth factors". In the absence of
rlcellulose platelet-derived growth factor (PDGF) a
S6Mi BHK21C13 potent heat-stable peptide hormone active
PE PE at nm concentrations (Scher et al., 1979)
63 <001 normal mesenchymal cells remain quies-
cent. Malignant transformation by SV40
6 6 <0 01 virus is associated with reduced depen-
dence on growth factors; i.e. with the
64 <001 acquisition of mitotic autonomy (Scher
et al., 1978). In a study ofa series ofrodent
age-independent mesenchymal tumours it was found (Cur-
rie, 1981) that these sarcomas display a
moter 12-tetra- range of dependence on the "wound-
be (TPA) was healing hormone" PDGF. Cells obtained
ad diluted in from tumours with minimal host-cell
centrations of infiltrate, and which readily metastasize
introls. A range (such as FS6M1) proliferate without a
was added to source of exogenous PDGF, whereas
andBHK21C13 others such as the FS6 remain quiescent
d its effects on without a source of growth factor. The
ed. As can be correlation between growth-factor-depen-
,dded TPA had dent growth and biological behaviour of
aal fibroblasts the tumours in vivo, including the extent
nhancement of of host-cell infiltration, suggested that
cells was seen host macrophages may play a role in
lony formation promoting tumour-cell proliferation.
-cted except at Evans (1977) examined the FS6 mouse
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sarcoma, and showed that whole-body
irradiation of the host prevented host
macrophage infiltration, and contrary to
conventional expectation, this was asso-
ciated with a delay in tumour growth. The
experiments described here show that host
macrophages infiltrating the FS6 tumour
can release a potent heat-stable mitogenic
material which, in monolayer cultures,
can induce proliferation in quiescent nor-
mal hamster and mouse fibroblasts and
FS6 tumour cells. These findings suggest
that the host-cell infiltrate may play an
important biological part in facilitating
tumour-cell proliferation. Since macro-
phages seem to be important in inducing
proliferation during wound healing, their
activity in promoting the growth of some
tumour cells can be regarded as an
aberrant form of wound healing.
Mantovani (1978) has previously exam-
ined supernatant fluids from cultures of
macrophages obtained from FS6 tumours,
and demonstrated either inhibited or
enhanced incorporation of labelled thy-
midine by FS6 cells, depending on the
duration of the cultures. Unfortunately,
the FS6 was not grown in syngeneic mice,
so the significance ofhis observations must
remain in doubt. Evans (1979) also
examined FS6 tumour macrophages, and
showed that spent medium obtained from
such cells stimulated proliferation of
murine lymphoma cells in sub-optimal
culture conditions.
Although mouse macrophages obtained
from the peritoneal cavity or from within
the FS6 tumour, release a product which
has potent growth-promoting activity for
normal hamster cells (BHK21C13) in
PDGF-deficient monolayer cultures, they
had no effect on the capacity ofthese cells
to form colonies in methylcellulose-con-
taining medium. They did, however,
exhibit potent colony-stimulating activity
when tested on FS6 fibrosarcoma cells.
Furthermore, an underlay of such macro-
phages (from the FS6 tumour or elicited
from the peritoneal cavity of normal mice
by proteose-peptone) released a diffusible
factor which conferred a high colony-
forming efficiency on FS6 cells, but not
on the normal hamster cells. The FS6M1
subline cells already showed anchorage-
independent growth which was unaffected
by a macrophage underlay.
Anchorage-independent growth is often
regarded as an important feature of the
malignant phenotype. But the expression
of this particular phenotypic feature by
FS6 cells is conditional upon the presence
ofaproduct ofhost macrophages. Further-
more, its expression is reversible; colonies
picked from macrophage-enhanced FS6
cultures provided clones with a low PE.
Furthermore, the addition of the known
tumour promoter TPA to cultures of FS6
cells in methylcellulose also induced a
dramatic, but again reversible, increase
in anchorage-independent growth by these
cells. The high colony-producing subline
FS6M1 was unaffected by TPA, except at
high (toxic) concentrations. The similari-
ties in biological effect ofTPA and a factor
released by host infiltrating macrophages
raisesthepossibilitythatmacrophagesmay
play a key role in the development of
tumours by providing a source of endo-
genous promoter. Chemically induced sar-
comas, heavily infiltrated by host macro-
phages, may represent just one stage in
tumour progression. In vivo passage ofthe
FS6 sarcoma, and other similar rat and
mouse sarcomas, usually leads to altered
biological behaviour, e.g. enhanced spon-
taneous metastasis associatedwithreduced
host macrophage infiltration.
Macrophages elicited by injection of
mice with BCG, or exposed in vitro to
lipopolysaccharide bacterial endotoxin,
were in these experiments growth in-
hibitory to normal hamster fibroblasts
and lytic to the mouse fibrosarcoma cells
FS6 and FS6M1. These toxic supernatants
contained high levels of arginase (Currie,
1978) and lost their toxicity and arginase
activity after heat inactivation. After
heating, these cytotoxic supernatants
showed substantial growth-promoting ac-
tivity, indicating that the macrophage
populations studied were releasing heat-
stable growth-promoting and heat-labile
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cytotoxic factors at the same time.
Whether different subsets of macrophages
are responsible for producing these factors
is unclear at present. However, these
observations could provide a possible
mechanism for the observation that the
same cultures of macrophages may release
growth-inhibiting and growth-promoting
supernatant factors at different times
(Evans, 1976; Mantovani, 1978).
Earlier work suggested (Currie &
Basham, 1978) that arginase-mediated
cytotoxicity is selective for transformed or
malignant cells because of their inability
to achieve quiescence under adverse
nutrition. The concomitant release of a
growth-promoting factor and a prolifera-
tion-dependent cytotoxic mechanism
could, therefore, constitute an important
cytotoxic combination.
Macrophages produce a range of dif-
ferent growth factors, since, unlike PDGF,
supernatants conditioned by macrophages
possess growth-promoting activity for
many celltypes; including endothelial cells
(Greenburg & Hunt, 1978) and lympho-
cytes (Nelson, 1976) as well as fibroblasts.
Filkins (1980) has recently described the
release of insulin-like activity by macro-
phages, and this may be involved in
growth stimulation. The production of a
variety of tissue-specific growth factors
whose predominant role seems to be the
induction of wound healing could account
for many phenomena referred to as the
immuno-stimulation of tumour cells
(Prehn, 1976).
These studies are supported by a programme
grant from the Medical Research Council. I thank
the Cancer Research Campaign for financial support.
Isobel MacCallum and George Booth provided
valuable assistance for which I am very grateful.
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